Resultados de la búsqueda 81-90 of 10673 for Severe obesity

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in ...

  3. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    Studies show that sleep apnea increases the risk of cardiovascular disease and is associated with obesity. However, it is unclear how sleep apnea affects fat ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in ...

  5. Médicos y departamentos

    Reeder GS, et al. Diagnosis of acute myocardial infarction. https://www.uptodate.com/contents/search. Accessed Dec. 29, 2025. What is a heart ...

  6. Médicos y departamentos

    Reeder GS, et al. Diagnosis of acute myocardial infarction. https://www.uptodate.com/contents/search. Accessed Dec. 29, 2025. What is a heart ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...